Martyn Boutelle,
Professor of Biomedical Sensors Engineering,
Imperial College London
Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College. His research group is multidisciplinary comprising, bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices that typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the acute traumatic brain injury including that caused by cardiac arrest, neonatal continuous monitoring and kidney transplantation monitoring. He runs the EPSRC funded Bio-nanofabrication suite designed to make microfluidic and biosensor biosensors using scalable methods to allow use in proof-of-concept clinical trials.
Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 190 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.
Microfluidics and Sensors: New Tools for Real-Time Clinical Monitoring
Monday, 26 September 2016 at 16:30
Add to Calendar ▼2016-09-26 16:30:002016-09-26 17:30:00Europe/LondonMicrofluidics and Sensors: New Tools for Real-Time Clinical MonitoringLab-on-a-Chip, Microfluidics and Microarrays World Congress 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
A goal for modern medicine is to protect vulnerable tissue by monitoring
the patterns of changing physical, electrical and chemical changes
taking place in tissue - ‘multimodal monitoring’. Clinicians hope such
information will allows treatments to be guided and ultimately
controlled based on the measured signals. Microfluidic lab-on-chip
devices coupled to tissue sampling using microdialysis provide an
important new way for measuring real-time chemical changes as the low
volume flow rates of microdialysis probes are ideally matched to the
length scales of microfluidic devices. Concentrations of key biomarker
molecules can then be determined continuously using either optically or
electrochemically (using amperometric, and potentiometic sensors).
Wireless devices allow analysis to take place close to the patient.
Droplet-based microfluidics, by digitizing the dialysis stream into
discrete low volume samples, both minimizes dispersion allowing very
rapid concentration changes to be measured, and allows rapid transport
of samples between patient and analysis chip. This talk will overview
successful design, optimization, automatic-calibration and use of both
continuous flow and droplet-based microfluidic analysis systems for
real-time clinical monitoring, using clinical examples from our recent
work.
Microfluidics and Sensors: New Tools for Real-Time Clinical Monitoring
Monday, 26 September 2016 at 16:30
Add to Calendar ▼2016-09-26 16:30:002016-09-26 17:30:00Europe/LondonMicrofluidics and Sensors: New Tools for Real-Time Clinical MonitoringLab-on-a-Chip, Microfluidics and Microarrays World Congress 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
A goal for modern medicine is to protect vulnerable tissue by monitoring
the patterns of changing physical, electrical and chemical changes
taking place in tissue - ‘multimodal monitoring’. Clinicians hope such
information will allows treatments to be guided and ultimately
controlled based on the measured signals. Microfluidic lab-on-chip
devices coupled to tissue sampling using microdialysis provide an
important new way for measuring real-time chemical changes as the low
volume flow rates of microdialysis probes are ideally matched to the
length scales of microfluidic devices. Concentrations of key biomarker
molecules can then be determined continuously using either optically or
electrochemically (using amperometric, and potentiometic sensors).
Wireless devices allow analysis to take place close to the patient.
Droplet-based microfluidics, by digitizing the dialysis stream into
discrete low volume samples, both minimizes dispersion allowing very
rapid concentration changes to be measured, and allows rapid transport
of samples between patient and analysis chip. This talk will overview
successful design, optimization, automatic-calibration and use of both
continuous flow and droplet-based microfluidic analysis systems for
real-time clinical monitoring, using clinical examples from our recent
work.
Add to Calendar ▼2016-09-26 00:00:002016-09-28 00:00:00Europe/LondonLab-on-a-Chip, Microfluidics and Microarrays World Congress 2016Lab-on-a-Chip, Microfluidics and Microarrays World Congress 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com